Sclerotherapy of idiopatic hydrocele with polidocanol: a study about 190 cases
Sallami, S.; Binous, M.Y.; Ben Rhouma, S.; Chelif, M.; Hmidi, M.; Nouira, Y.; Ben Rais, N.; Horchani, A.
La Tunisie Medicale 89(5): 440-444
2011
ISSN/ISBN: 0041-4131 PMID: 21557180 Document Number: 655076
To evaluate the efficacy and side-effects of Polidocanol used as sclerosing agent for testicular hydrocele. One hundred and ninety men, with a median age of 55,9 years (40-89), treated for idiopatic hydrocele were assessed. After puncture and aspiration, the empty sac was instilled with 3% Polidocanol. We recorded recurrence, complications and associated pain on a visual analogue scale. With a median follow-up of 19 months, The cure rate of hydroceles after one sclerotherapy session was 62,1%, and the overall cure rate using the procedure was 82,6%. Re-instillation was done for recurrences in 41% of patients. Polidocanol therapy was almost pain-free. A low rate of complications was observed. Polidocanol is a useful sclerosing agent for treating testicular hydrocele. Due to its ease of administration, low frequency of complications, high rate of effectiveness, and excellent tolerability; we recommend sclerotherapy with polidocanol as the primary treatment for hydroceles.
Document emailed within 1 workday
